Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 91
Selected: 0
NCT IDTitle
NCT05131386Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas
NCT06844318Impact of IBD Activity on Frailty in Patients Over 60 Years
NCT01310010Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia
NCT03727113Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors
NCT00541840Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma
NCT01212796Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETH
NCT03980925Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.
NCT01742026Aspergillus PCR Early Detection in High Risk Oncohematological Patients
NCT01567488Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET
NCT01562951Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants
NCT00702611Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis
NCT04986085Nutrition in Gastroenteropancreatic Neuroendocrine Tumor
NCT07061080Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab
NCT01683123Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT
NCT05809830Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas
NCT05660954Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.
NCT03242382Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.
NCT05674422GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer.
NCT05201612Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC).
NCT00789763Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma
NCT00103168Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
NCT02921555Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis
NCT04293419Durvalumab (MEDI4736) Plus Total Neoadjuvant Therapy (TNT) in Locally Advanced Rectal Cancer
NCT03985722Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients
NCT05390671CAR-T Cell Therapy in Patients With Hematological Malignancies
NCT05918302Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
NCT03142516FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status
NCT04595266Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease
NCT01493713Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer
NCT02904590A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease
NCT04383288ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities
NCT03277924Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas
NCT01280201Pazopanib as Single Agent in Advanced NETs
NCT02254941Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer
NCT02402062A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours
NCT07248644Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission
NCT04181970Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK
NCT03152565Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Metastatic Colorectal Cancer Patients
NCT02806648A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET)
NCT06211543Letermovir (LMV) Prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients With CMV Seropositive Donors: an Exploratory Study From Spanish GETH/TC Centers
NCT02678780Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors
NCT02841865Radiological Response of Pancreatic Neuroendocrine Tumors: Comparison Between the Choi and the RECIST Criteria
NCT02246127Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor
NCT06837090Retrospective Analysis of the Experience With Larotrectinib in Patients With Solid Neoplasms With NTRK Fusion in Spain (SPAINTRK)
NCT05698745Immunological Characteristics of Preclinical IBD
NCT02066285Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma
NCT02713763Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib
NCT01104298Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS
NCT05146440Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor
NCT03000374Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery